How many insider trades does FilingIQ track for RDGL?

FilingIQ tracks 40 Form 4 insider transactions for RDGL (VIVOS INC), covering filings from Oct 10, 2018 onwards. 1 of those were filed in the last 90 days.

Are RDGL insiders net buyers or net sellers?

Across the full Form 4 history for RDGL, 28 transactions (70%) were open-market purchases and 2 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does RDGL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is RDGL in?

VIVOS INC (RDGL) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $29.93M.

RDGL insider trading

OTC Markets OTCQB Healthcare

VIVOS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

70% / 5%

Market cap

$29.93M

About VIVOS INC

Vivos Inc., a radiation oncology medical device company, engages in the development of yttrium-90-based precision radionuclide therapy devices for the treatment of non-resectable tumors in the United States. The company develops RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing PLGA-g-PEG polymers; PrecisionGel, a hydrogel polymer platform for delivering active pharmaceutical ingredients and therapeutic agents; Duncan Chiller, a general laboratory equipment for non-water localized chilling; and other products under the Alpha-Gel, Beta-Gel, Gamma-Gel, and Peltier Chiller brands. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Kennewick, Washington.

Company website: radiogel.com

RDGL insider activity at a glance

FilingIQ has scored 40 insider transactions for RDGL since Oct 10, 2018. The most recent filing in our index is dated May 11, 2026.

Across the full history, 28 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RDGL insider trades is 63.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live RDGL trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for RDGL?: FilingIQ tracks 40 Form 4 insider transactions for RDGL (VIVOS INC), covering filings from Oct 10, 2018 onwards. 1 of those were filed in the last 90 days.
Are RDGL insiders net buyers or net sellers?: Across the full Form 4 history for RDGL, 28 transactions (70%) were open-market purchases and 2 (5%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RDGL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is RDGL in?: VIVOS INC (RDGL) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $29.93M.

Methodology & sources

Every RDGL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.